Granules India informs about press release

14 Jun 2023 Evaluate

Granules India has informed that it enclosed the press release dated on 14th June 2023, titled ‘Granules India Limited Receives ANDA Approval for Levetiracetam Tablets in record 9 months.’

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

552.70 -21.25 (-3.70%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×